Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2004 1
2005 1
2013 1
2014 1
2017 1
2018 2
2019 1
2022 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

10 results

Results by year

Filters applied: . Clear all
Page 1
Corrected and Republished from: "A Novel, Multiple-Antigen Pneumococcal Vaccine Protects against Lethal Streptococcus pneumoniae Challenge".
Chan WY, Entwisle C, Ercoli G, Ramos-Sevillano E, McIlgorm A, Cecchini P, Bailey C, Lam O, Whiting G, Green N, Goldblatt D, Wheeler JX, Brown JS. Chan WY, et al. Among authors: entwisle c. Infect Immun. 2022 Jan 25;90(1):e0084618a. doi: 10.1128/IAI.00846-18a. Epub 2018 Dec 10. Infect Immun. 2022. PMID: 35076289 Free PMC article.
Correction for Chan et al., "A Novel, Multiple-Antigen Pneumococcal Vaccine Protects against Lethal Streptococcus pneumoniae Challenge".
Chan WY, Entwisle C, Ercoli G, Ramos-Sevillano E, McIlgorm A, Cecchini P, Bailey C, Lam O, Whiting G, Green N, Goldblatt D, Wheeler JX, Brown JS. Chan WY, et al. Among authors: entwisle c. Infect Immun. 2022 Jan 25;90(1):e0063921. doi: 10.1128/IAI.00639-21. Epub 2022 Jan 25. Infect Immun. 2022. PMID: 35076290 Free PMC article. No abstract available.
A Novel, Multiple-Antigen Pneumococcal Vaccine Protects against Lethal Streptococcus pneumoniae Challenge.
Chan WY, Entwisle C, Ercoli G, Ramos-Sevillano E, McIlgorm A, Cecchini P, Bailey C, Lam O, Whiting G, Green N, Goldblatt D, Wheeler JX, Brown JS. Chan WY, et al. Among authors: entwisle c. Infect Immun. 2019 Feb 21;87(3):e00846-18. doi: 10.1128/IAI.00846-18. Print 2019 Mar. Infect Immun. 2019. PMID: 30530620 Free PMC article. Corrected and republished.
Anti-tumour therapeutic efficacy of OX40L in murine tumour model.
Ali SA, Ahmad M, Lynam J, McLean CS, Entwisle C, Loudon P, Choolun E, McArdle SE, Li G, Mian S, Rees RC. Ali SA, et al. Among authors: entwisle c. Vaccine. 2004 Sep 9;22(27-28):3585-94. doi: 10.1016/j.vaccine.2004.03.041. Vaccine. 2004. PMID: 15315837 Free article.
Tumor regression induced by intratumor therapy with a disabled infectious single cycle (DISC) herpes simplex virus (HSV) vector, DISC/HSV/murine granulocyte-macrophage colony-stimulating factor, correlates with antigen-specific adaptive immunity.
Ali SA, Lynam J, McLean CS, Entwisle C, Loudon P, Rojas JM, McArdle SE, Li G, Mian S, Rees RC. Ali SA, et al. Among authors: entwisle c. J Immunol. 2002 Apr 1;168(7):3512-9. doi: 10.4049/jimmunol.168.7.3512. J Immunol. 2002. PMID: 11907113